PharmaBlock Group

PharmaBlock is committed to using our innovation, voice, reach and expertise to support more for the entire community.

Thanks to JJ Conde, Executive Director Process R&D at PharmaBlock USA,our actions and voice made a positive impact within the world.

Due to its high selectivity, mild reaction conditions, and tunable catalysis properties, biocatalysis has become one of the greenest technologies in the pharmaceutical industry.

PharmaBlock holds an in-house enzyme stock, complemented with many well-testified commercial enzymes. Our biocatalysis capability can facilitate the customized process and production of APIs and intermediates. Providing better, faster, and lower-cost biocatalysis solution to our customers is our goal.

In this article, Dr. Larry Y Wang discussed the biocatalysis technology process development in the pharmaceutical industry and shares the experience with cases.

Read more:
https://www.pharmablock.com/index.php/resource.html